HomeCompareHXLTF vs JNJ

HXLTF vs JNJ: Dividend Comparison 2026

HXLTF yields 1081.67% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HXLTF wins by $37484257.68M in total portfolio value
10 years
HXLTF
HXLTF
● Live price
1081.67%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37484257.71M
Annual income
$31,716,242,220,411.04
Full HXLTF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — HXLTF vs JNJ

📍 HXLTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHXLTFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HXLTF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HXLTF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HXLTF
Annual income on $10K today (after 15% tax)
$91,941.59/yr
After 10yr DRIP, annual income (after tax)
$26,958,805,887,349.38/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, HXLTF beats the other by $26,958,805,883,363.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HXLTF + JNJ for your $10,000?

HXLTF: 50%JNJ: 50%
100% JNJ50/50100% HXLTF
Portfolio after 10yr
$18742128.87M
Annual income
$15,858,121,112,550.22/yr
Blended yield
84.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HXLTF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HXLTF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHXLTFJNJ
Forward yield1081.67%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$37484257.71M$30.3K
Annual income after 10y$31,716,242,220,411.04$4,689.40
Total dividends collected$37048221.41M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HXLTF vs JNJ ($10,000, DRIP)

YearHXLTF PortfolioHXLTF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$118,867$108,166.58$10,592$272.30+$108.3KHXLTF
2$1,328,813$1,201,625.29$11,289$357.73+$1.32MHXLTF
3$13,976,035$12,554,205.81$12,123$472.89+$13.96MHXLTF
4$138,357,363$123,403,005.69$13,141$629.86+$138.34MHXLTF
5$1,289,764,067$1,141,721,688.15$14,408$846.81+$1289.75MHXLTF
6$11,326,872,371$9,946,824,819.24$16,021$1,151.60+$11326.86MHXLTF
7$93,759,270,197$81,639,516,760.49$18,122$1,588.22+$93759.25MHXLTF
8$731,891,497,691$631,569,078,579.60$20,930$2,228.20+$731891.48MHXLTF
9$5,390,668,685,761$4,607,544,783,231.61$24,792$3,191.91+$5390668.66MHXLTF
10$37,484,257,714,175$31,716,242,220,411.04$30,274$4,689.40+$37484257.68MHXLTF

HXLTF vs JNJ: Complete Analysis 2026

HXLTFStock

HeliosX Lithium & Technologies Corp. engages in the identification, evaluation, acquisition, and exploration of mineral properties in Canada, Argentina, and the United States. The company also holds 100% interest in the Teels project consisting of 403 placer claims, which covers an area of 7,914 acres located in West Central Nevada, the United States; the Alkali Spring project covering an area of 2,780 acres located in Nevada, the United States; and the Fox Creek Lithium project that covers an area of 315,060 acres located in Alberta, Canada. It also holds 49% interest in the Guayatoyoc project comprising 25 concessions covering an area of 230,000 acres located in the Province of Jujuy, Argentina. HeliosX Lithium & Technologies Corp. is headquartered in Calgary, Canada.

Full HXLTF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this HXLTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HXLTF vs SCHDHXLTF vs JEPIHXLTF vs OHXLTF vs KOHXLTF vs MAINHXLTF vs ABBVHXLTF vs MRKHXLTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.